Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells

Area of Science:

• Oncology
• Stem Cell Biology
• Pharmacology

Background:

• Lung cancer remains a major global health concern with high mortality rates.
• Cancer stem cells (CSCs) are implicated in therapeutic resistance and disease recurrence in various cancers.
• Salinomycin has demonstrated efficacy against CSCs in other cancer types, like breast cancer and leukemia.

Purpose of the Study:

• To investigate the in vitro anticancer effects of salinomycin on lung cancer cells, specifically targeting cancer stem cells.
• To evaluate salinomycin's impact on the viability, tumorosphere formation, and stem cell marker expression in A549 lung cancer cells.

Main Methods:

• In vitro assays including sulforhodamine B and colony formation assays were used to assess cytotoxicity.
• Flow cytometry was employed to analyze the effect of salinomycin on lung cancer tumorospheres derived from aldehyde dehydrogenase (ALDH)-positive A549 cells.
• Real-time reverse transcription polymerase chain reaction (RT-PCR) was utilized to quantify the expression of stem cell markers (OCT-4, NANOG, SOX2).

Main Results:

• Salinomycin exhibited significant in vitro anticancer activity against the A549 lung cancer cell line.
• The drug effectively disrupted lung cancer tumorospheres formed by ALDH-positive A549 cells.
• Salinomycin treatment led to a significant decrease in the expression of OCT-4, NANOG, and SOX2 stem cell markers.

Conclusions:

• Salinomycin demonstrates potent in vitro activity against lung cancer stem cells.
• The drug reduces tumorosphere formation and key stemness markers in lung cancer cells.
• Salinomycin presents a promising therapeutic candidate for future lung cancer chemotherapy strategies.